Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Vanderbilt-Ingram Cancer Center
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Ingrid Meszoely, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00651976
First received: April 2, 2008
Last updated: July 13, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2019
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)